CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)

BACKGROUND: Accurate and early prognosis of disease is essential to clinical decision making, particularly in diseases, such as HCC, that are typically diagnosed at a late stage in the course of disease and therefore carry a poor prognosis. CDCA5 is a cell cycle regulatory protein that has shown pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yunhong, Wu, Jianlin, Chagas, Cristian, Du, Yichao, Lyu, Huan, He, Yunhong, Qi, Shouliang, Peng, Yong, Hu, Jiani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267780/
https://www.ncbi.nlm.nih.gov/pubmed/30497429
http://dx.doi.org/10.1186/s12885-018-5072-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267780/
https://www.ncbi.nlm.nih.gov/pubmed/30497429
http://dx.doi.org/10.1186/s12885-018-5072-4

Ejemplares similares